Back to Company Profile
Alpha

Alpha Profiles · Company Profile

Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics, Inc. is a biotechnology enterprise dedicated to discovering, advancing, and bringing to market therapeutic agents specifically designed for patients with genetically characterized tumors.

https://registry.alpha.ac/companies/black-diamond-therapeutics-inc

Black Diamond Therapeutics, Inc. logo
Entity
Public listing published
Primary listing
NASDAQ: BDTX
Verification
Partially verified
Last reviewed
2026-09-15T20:39:08.444706+00:00

Overview

Black Diamond Therapeutics, Inc. is a biotechnology enterprise dedicated to discovering, advancing, and bringing to market therapeutic agents specifically designed for patients with genetically characterized tumors. A core part of its pipeline is BDTX-189, an irreversible small molecule inhibitor. This compound is engineered to neutralize oncogenic proteins driven by non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) driver mutations. The fi

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

0 public records

Executive roster coverage is NOT_ASSERTED. An empty list is not evidence that this company has no executive team.

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 15, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.

Board roles

7 public records

Source record

Alpha canonical company public projection

Supports Company identity, Published leadership, Entity status boundary

Reviewed 2026-09-15T20:39:08.444706+00:00

Generated 2026-09-16T02:58:29.152Z

Data as of 2026-09-15T20:39:08.444706+00:00

https://registry.alpha.ac/companies/black-diamond-therapeutics-inc